Quantification of Reserve Pool Dopamine in Methionine Sulfoxide Reductase A Null Mice by Ortiz, Andrea Naomi et al.
QUANTIFICATION OF RESERVE POOL DOPAMINE IN
METHIONINE SULFOXIDE REDUCTASE A NULL MICE
Andrea N. Ortiz1, Derek B. Oien2,3, Jackob Moskovitz2, and Michael A. Johnson1,*
1Department of Chemistry and R. N. Adams Institute of Bioanalytical Chemistry, Lawrence, KS
66045 USA
2Department of Pharmacology & Toxicology, Lawrence, KS 66045 USA
Abstract
Methionine sulfoxide reductase A knockout (MsrA−/−) mice, which serve as a potential model for
neurodegeneration, suffer from increased oxidative stress and have previously been found to have
chronically elevated brain dopamine content levels relative to control mice. Additionally, these
high levels parallel increased presynaptic dopamine release. In this work, fast-scan cyclic
voltammetry at carbon-fiber microelectrodes was used to quantify striatal reserve pool dopamine
in knockout mice and wild-type control mice. Reserve pool dopamine efflux, induced by
amphetamine, was measured in brain slices from knockout and wild type mice in the presence of
α-methyl-p-tyrosine, a dopamine synthesis inhibitor. Additionally, the stimulated release of
reserve pool dopamine, mobilized by cocaine, was measured. Both efflux and stimulated release
measurements were enhanced in slices from knockout mice, suggesting that these mice have
greater reserve pool dopamine stores than wild-type and that these stores are effectively
mobilized. Moreover, dopamine transporter labeling data indicate that the difference in measured
dopamine efflux was likely not caused by altered dopamine transporter protein expression.
Additionally, slices from MsrA−/− and wild-type mice were equally responsive to increasing
extracellular calcium concentrations, suggesting that potential differences in either calcium entry
or intracellular calcium handling are not responsible for increased reserve pool dopamine release.
Collectively, these results demonstrate that MsrA−/− knockout mice maintain a larger dopamine
reserve pool than wild-type control mice, and that this pool is readily mobilized.
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The abnormal regulation of dopamine (DA) has been associated with multiple
neurodegenerative disease states (Bird and Iversen, 1974, Morgan et al., 1987), yet the role
of DA reserve pool storage and mobilization in the pathophysiology of these conditions is
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
*Corresponding Author: To whom correspondence should be addressed: Michael A. Johnson, The University of Kansas, Department
of Chemistry, 1251 Wescoe Hall Drive, 2010 Malott Hall, Lawrence, KS 66047-7572, Telephone: (785) 864-4629, Fax: (785)
864-4629, johnsonm@ku.edu.
3Current address: Boehringer Ingelheim Vetmedica, Inc., Fort Dodge, IA 50501 USA
Section Editor: Cellular, Dr. Menahem Segal, Weizmann Institute of Science, Department of Neurobiology, Hertzl Street, Rehovot
76100, Israel
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Neuroscience. Author manuscript; available in PMC 2012 September 23.
Published in final edited form as:













now just being revealed. Many of these conditions, such as Parkinson’s disease,
Huntington’s disease, and Lou Gehrig’s disease, have been associated with the increased
production or reactive oxygen species, thereby enhancing the degree of cell oxidative stress
in the brain (Patten et al., 2010, Cohen, 1983, Perez-Severiano et al., 2004).
Interestingly, elevated DA levels have also been associated with enhanced oxidative stress
(Oien et al., 2008b). Indeed, one model of oxidative stress, methionine sulfoxide reductase
A knockout (MsrA−/−) mice, have been reported to have chronically high brain DA levels
(Oien et al., 2008b). These mice lack the antioxidant enzyme MsrA, which is part of the Msr
system. Methionine sulfoxide posttranslational modifications can be reversed by the Msr
system, which consists of MsrA (reduces S methionine sulfoxide enantiomer) and MsrB
(reduces R methionine sulfoxide enantiomer) (Moskovitz, 2005). The MsrA−/− mouse is
hypersensitive to oxidative stress, accumulates higher levels of carbonylated protein, and
expresses brain pathologies associated with neurodegenerative diseases (Moskovitz et al.,
2001, Pal et al., 2007). Recent studies have shown that these mice have abnormally high DA
levels in the brain at the ages of 6 and 12 months, compared to wild type (WT) control mice.
Additionally, these high levels parallel an increased presynaptic DA release when stimulated
in vitro without drug treatments.
A possible mechanism for an increase in stimulated DA release in MsrA−\− mice involves
the mobilization of reserve pool DA. In general, DA-containing vesicles are believed to be
separated into three pools: the readily releasable pool (RRP), the recycling pool, and the
reserve pool (Neves and Lagnado, 1999, Rizzoli and Betz, 2005). The RRP undergoes
exocytosis upon mild stimulation and is replenished by the mobilization of the recycling
pool vesicles. The reserve pool, mobilized upon prolonged periods of synaptic activity
(Neves and Lagnado, 1999), is the largest pool consisting of 80–90% of the total vesicles
(Rizzoli and Betz, 2005). Pharmacological manipulations, using a combination of alpha-
methyl-p-tyrosine (aMPT) and either cocaine (COC) or amphetamine (AMPH) (Venton et
al., 2006, Ortiz et al., 2010), have been used to quantitatively measure reserve pool
dopamine.
Other factors, such as calcium transport, may also influence the amplitude of stimulated
dopamine release plots. Transient increases in intracellular calcium concentration trigger
vesicular exocytosis (Nachshen and Sanchez-Armass, 1987, Kume-Kick and Rice, 1998) as
well as the movement of RRP and reserve pool vesicles (Rose et al., 2002). Moreover, the
increase in oxidative stress may result in calcium dysregulation. For example, the activity of
calmodulin, a calcium regulatory protein that activates the plasma membrane calcium
ATPase (PMCA), diminishes due to oxidative post-translational modifications as tissues age
(Michaelis et al., 1996). The oxidation of specific methionines in calmodulin results in about
a 50% reduction of PMCA activation (Bartlett et al., 2003), thereby impairing the ability of
cells to clear calcium from the cell (Palacios et al., 2004). Oxidized calmodulin can
accumulate in brain tissues as a result of low antioxidant levels and it is speculated that
oxidation of methionines on calmodulin may be acting as a molecular switch in calcium
regulation, oxidative stress, and DA release (Chen et al., 2001, Bigelow and Squier, 2005).
To investigate possible mechanisms underlying elevated DA content and release found in
MsrA−/− mice, fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes was
used to measure the mobilization and efflux of reserve pool DA in striatal brain slices from
MsrA−/− mice and WT control mice (Oien et al., 2008b). We hypothesized that the DA
reserve pool is enhanced in MsrA−/− mice compared to WT control mice. In order to
measure reserve pool DA, slices were pre-treated with αMPT and then treated with either
AMPH, to measure the efflux of reserve pool DA, or with COC, to measure the stimulated
release of mobilized DA reserve pool vesicles. Collectively, our results suggest that reserve
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pool DA is more abundant in the MsrA−/− striatum and that the number of vesicles is greater
compared to WT controls.
Experimental Procedures
Animals
The MsrA−/− and WT control mice have been described previously (Moskovitz et al., 2001).
All mice used in these experiments were fed ad libitum, housed with 12 h of light per day,
and caged individually. All procedures and conditions of live mice, including euthanasia,
were approved by the University of Kansas Institutional Animal Care and Use Committee.
Every effort was made to minimize the number of animals used and animal suffering.
Brain Slice Preparation
Brain slices of 12-month-old MsrA−/− mice and age-matched WT control mice were
prepared as previously described (Johnson et al., 2006). Brain slices were used as an
experimental preparation because they allow for the direct measurement of locally evoked
DA release and generally provide higher throughput than whole animal preparations. Mice
were anesthetized by isoflurane inhalation and then decapitated. The brain was immediately
removed and placed in ice cold artificial cerebrospinal fluid (aCSF) consisting of (mM):
NaCl 126, KCl 2.5, NaH2PO4 1.2, CaCl2 2.4, MgCl2 1.2, NaHCO3 25, HEPES 20, and D-
Glucose 11. The pH of the aCSF was adjusted to 7.4. The cerebellum was removed from the
brain using a razor blade and the brain was then mounted on an aluminum block. A
vibratome slicer (Leica, Wetzlar, Germany) was used to make 300 µm thick coronal slices.
Each brain slice was equilibrated in the superfusion chamber which was maintained at 34°C,
through which aCSF flowed at a continuous rate of 2 mL/min, prior to obtaining
measurements.
DA Release in Brain Slices
Carbon-fiber microelectrodes were fabricated using a single 7 µm diameter carbon-fiber
(Goodfellow Cambridge Ltd, Huntingdon, U.K.) that was aspirated through a glass capillary
tube (1.2 mm outer diameter, 0.68 mm inner diameter, 20 mm long, A-M Systems, Inc.
Carlsborg, WA), and was pulled using a heated coil puller (Narishige International USA,
Inc., East Meadow, NY) (Kraft et al., 2009). The carbon-fiber was trimmed to about 25 µM
and further insulated using with epoxy resin (EPON resin 815C, EPIKURE 3234 curing
agent, Miller-Stephenson, Danbury, CT, USA), and then cured at 100°C for 1 h. The
electrodes were backfilled with 0.5 M potassium acetate to provide an electrical connection
between the carbon fiber and an inserted silver wire.
A triangular waveform was applied to the carbon-fiber electrode starting at −0.4 V,
increasing to +1.0 V, and then scanning back down to −0.4 V. For stimulated release
measurements, a scan rate of 300 V/s and an update rate of 60 cyclic voltammograms (CVs)
per second were used. For measurements of AMPH-induced DA efflux, an update rate of 5
CVs was used to limit the memory space occupied by the file. A headstage amplifier (UNC
Chemistry Department Electronics Design Facility, Chapel Hill, NC) was interfaced with a
computer via a breakout box and custom software provided by R.M. Wightman and
M.L.A.V. Heien (University of North Carolina, Chapel Hill). A Ag/AgCl reference
electrode consisted of a chorided silver wire. The carbon fiber microelectrode was inserted
100 µm into the dorsolateral caudate-putamen region of the striatum between the prongs of a
bipolar stimulation electrode (Plastics One, Roanoke, VA), which was separated by a
distance of 200 µm. A single pulse at 60 Hz was applied to the brain slice and the current
was then measured at the peak oxidation potential for DA (about +0.6 V versus Ag/AgCl
reference electrode). Working electrodes were calibrated with DA standards of known
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concentration in a flow cell before and after each use. The average of pre- and post-
calibration measurements was used as the calibration factor. Drugs were introduced into the
brain slice superfusion chamber by opening a three-way valve that allowed the desired
solution to flow by gravity feed.
For AMPH-induced DA efflux experiments, brain slices were stimulated with single
electrical stimulus pulses until the magnitude of evoked DA release was consistent between
measurements. Brain slices were then treated with 50 µM aMPT. During this treatment,
stimulated DA release was measured every 5 min. Once DA release diminished, 20 µM
AMPH was added to the aCSF/aMPT solution and a 25 min duration file was collected.
To measure electrically evoked DA release from mobilized reserve pool vesicles, the same
procedure for pre-treatment with aMPT was used. However, slices were treated with 20 µM
COC after stimulated release was diminished. During this treatment, electrically-evoked
release was measured every 5 minutes.
Sensitivity of DA release to extracellular calcium
To measure changes in the sensitivity to calcium in MsrA−/− mice DA release evoked by a
single electrical stimulus pulse was first measured in slices with aCSF that contained 2.4
mM calcium. Next, aCSF containing 0 mM calcium was introduced into the superfusion
chamber. Once DA release disappeared, brain slices were cumulatively treated with aCSF
containing 0.6, 1.2, 1.8, and 2.4 mM calcium. Slices were treated with each concentration
for 15 min, with files collected every five 5 min using a single pulse stimulation. Values
obtained at the 15 min point were used in Fig. 4.
Immunoblotting
MsrA−/− and WT brains were dissected from post-mortem mice. Each striatal lysate was
placed in a glass tube and homogenized with Teflon in 50 mM HEPES buffer pH 7.4 plus
protease inhibitors (Roche) at 4°C. Homogenized extract was centrifuged for 20 min to
separate the membrane fraction. Buffer containing 50 mM HEPES, 0.62% CHAPS, and 150
mM NaCl was added to each membrane fraction and agitated for 30 min. Each fraction was
centrifuged for 20 min. Protein concentration of the supernatant was determined by BCA
Protein Assay Kit (Pierce). Equal protein amounts (20 µg) of each soluble membrane
fraction was loaded into a HEPES 4–20% Protein Gel (Pierce, Pittsburg, PA) for
electrophoretic separation. Proteins were transferred to a nitrocellulose membrane and
blocked overnight in 5% dry milk in buffer. DAT band was detected using primary rabbit
anti-DAT antibodies (1:1000; Chemicon, Billerica, MA). Peroxide-conjugated goat-anti-
rabbit antibodies were used as secondary antibodies (1:2000; Bio-Rad, Hercules, CA).
Protein bands were visualized by chemiluminescent substrate and exposure to
autoradiography film. Densitometry analysis was done using ImageJ software (publicly
available software obtained from the National Institutes of Health website).
Statistical Analyses
Data were analyzed by ANOVA or students t-test using GraphPad Prism 4.03 (GraphPad
Software, Inc., La Jolla, CA). All numerical values are represented as mean ± SEM. A p
value of 0.05 or less was considered significant.
Results
Reserve Pool DA Levels
It has been previously demonstrated that in MsrA−/− mice stimulated DA release, evoked by
a single-pulse electrical stimulation, is significantly higher than that of WT controls (Oien et
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al., 2008b). To determine if reserve pool DA is similarly more abundant in MsrA−/− mice,
striatal brain slices were subjected to treatment with aMPT and AMPH-induced efflux was
measured. Each slice was treated with 50 µM aMPT to inhibit tyrosine hydroxylase, the rate
limiting enzyme in DA synthesis. A stimulus pulse was then applied to the slice every 5 min
until DA release was diminished. At this point, DA remaining in terminals consisted only of
reserve pool DA. The slices were then treated with 20 µM AMPH, a competitive DAT
inhibitor that induces the quantitative efflux of cytosolic and vesicular DA. AMPH enters
the pre-synaptic terminals in one of two ways: either by lipophilic diffusion through
membranes or by passage through DAT protein molecules (Fischer and Cho, 1979, Liang
and Rutledge, 1982). AMPH displaces vesicular DA into the cytoplasm and induces DA
reverse transport, caused by allosteric translocation of the DAT protein molecules (Chiueh
and Moore, 1975, Jones et al., 1998). The AMPH induced efflux of DA was measured over
the course of 25 min and the amplitude of the DA peak ([DA]AMPH) was used to determine
the amount of DA released (Fig.1a). A CV, which has an oxidation peak at ~0.6 V and a
reduction peak at ~−0.2 V, shown at the peak current on this efflux curve indicates that the
species released by AMPH treatment is DA. In MsrA−/− mice, AMPH-induced DA efflux
was significantly greater than that observed in WT control mice, indicating that the striatal
DA reserve pool is enhanced in MsrA−/− mice (Fig. 1b; p = 0.022; MsrA−/−, 7.02 ± 1.42 µM,
n = 5 mice; WT, 5.63 ± 0.33 µM, n = 4 mice).
Mobilization of Reserve Pool DA
To identify differences in the exocytotic release of mobilized DA reserve pool vesicles, DA
release, electrically evoked in striatal brain slices from MsrA−/− and WT mice control mice,
was measured with FSCV (Fig. 2a). Once DA release peak amplitude was the same between
separate stimulations in the absence of drug, aMPT was added to the perfusate at a final
concentration of 50 µM in order to stop DA synthesis. After DA release was diminished,
COC was added to the aMPT/aCSF solution at a final concentration of 20 µM. COC has
previously been shown to mobilize reserve pool DA (Venton et al., 2006). DA release was
electrically evoked by the application of locally applied single stimulus pulses every 5 min
throughout the entire process. The addition of COC caused stimulated DA release to grow in
both MsrA−\− and WT control slices. Although COC treatment caused DA release to
increase to similar levels in MsrA−/− and WT control slices, DA release reappeared for a
longer amount of time in slices from MsrA−/− mice (~180 min) compared to slices from WT
mice (~80 min)(Fig. 2b). The area under the curve generated using slices from WT mice was
40% of that generated using slices from MsrA−/− mice.
DAT Protein Levels
The DAT is a transmembrane protein that moves DA from the synaptic cleft into the
presynaptic neuron. In membrane fractions of MsrA−/− and WT mice, no difference in DAT
protein levels was detected (Fig. 3; p = 0.65; MsrA−/−, 115.6 ± 4.1 %, n = 3 mice; WT,
100.0 ± 19.8 %, n = 3 mice). These data are consistent with a previous report that showed
synaptic DA clearance was similar between MsrA−/− and WT mice (Oien et al., 2008).
Extracellular Calcium Sensitivity
Vesicular DA exocytosis in the striatum is directly dependent on available extracellular
calcium, which enters pre-synaptic terminals by voltage-gated calcium channels during
membrane depolarization (Heuser and Reese, 1973; Cremona and De Camilli, 1997). In
order to evaluate whether the calcium dependency of release was altered in MsrA−/− mice,
brain slices were treated with various concentrations of extracellular calcium and stimulated
DA release was measured (Fig. 4). All peak DA release values were normalized against
peak DA release obtained at 2.4 mM Ca2+, which is the concentration of Ca2+ present in the
aCSF that was used for measuring the total amount of DA present in the reserve pool (Figs 1
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and 2). The purpose of this normalization was to minimize variation caused by heterogeneity
in dopaminergic innervation found in the striatum. A two-way ANOVA did not reveal an
overall genotype effect on DA release throughout the entire range of extracellular calcium
concentrations (Fig. 4; p = 0.97; F1,44 = 0.00; MsrA−/−, n = 4 to 6 mice; WT, n = 6 mice).
Discussion
Previous studies using MsrA−/− mice have shown that DA release evoked using a single-
pulse stimulation is increased (Oien et al., 2008b). In the present study, differences in DA
reserve pool storage and mobilization in striatal brain slices from MsrA−/− mice and WT
control mice were examined. AMPH-induced DA efflux, following pre-treatment with
αMPT, was increased in striatal brain slices from MsrA−/− mice compared to those of WT
littermates. Moreover, MsrA−/− slices showed an enhanced degree of COC-induced
mobilization of DA reserve pool vesicles compared to WT. Furthermore, slices from
MsrA−/− mice and WT control mice were equally sensitive to changes in extracellular
calcium concentration.
Initial experiments were aimed at determining if alterations in either DAT or calcium
regulation preferentially enhanced DA release in MsrA−/− mice. Our previous work has
shown that the efficiency of DA reuptake by DAT is similar in MsrA−/− and WT mice (Oien
et al., 2008b). Furthermore, here we show that DAT protein levels are similar in MsrA−/−
and WT mice. This result further supports the concept that DAT function and protein levels
are not altered in the absence of MsrA. Therefore, we expect that COC and AMPH effects
on the DAT would be similar in both mice genotypes.
The exocytotic release of DA during synaptic transmission is mediated by calcium-
dependent fusion with the active zone (Heuser and Reese, 1973; Cremona and De Camilli,
1997; Kavalali, 2006). Thus, the ability of extracellular calcium to enter through N- and P/
Q-type voltage-gated calcium channels (VGCCs) located at the active zone exerts a strong
influence over neurotransmitter release (Fox and Currie, 1997). We observed no difference
in electrically evoked DA release between MsrA−/− and WT slices when extracellular
calcium concentrations were increased, suggesting that the VGCCs were functioning
similarly. However, it is important to note that this experiment, due to its limited scope,
cannot rule out potential alterations in other calcium handing mechanisms in MsrA−/− mice,
and the possibility that such alterations may somehow influence the ability of terminals to
release DA, especially since intracellular calcium can influence the movement of vesicular
DA between RRP and reserve pools (Rose et al., 2002).
One potential mechanism that could increase intracellular calcium levels, although not
supported by the data presented in this report, is the oxidative inactivation of calcium
regulatory proteins. In particular, methionine oxidation of calcium regulatory proteins, such
as calmodulin (Michaelis et al., 1996) and calcium/calmodulin kinase II (Erickson et al.,
2008), increases with age and is also increased in selenium deficient MsrA−/− mice
compared to WT control mice (Moskovitz, 2007). Data obtained using patch clamp methods
in several cell types (Zucker and Regehr, 2002), including studies conducted using
dopaminergic retinal amacrine cells (Borges et al., 1995) and retinal bipolar cells (Gomis et
al., 1999), suggest that the translocation of reserve pool vesicles are influenced by changes
in intracellular Ca2+ levels. Thus, it seems plausible that fluctuations in intracellular Ca2+
levels associated with a lack of calcium chelating ability would influence reserve pool DA
mobilization in MsrA−/− mice.
To assess the content and mobilization of reserve pool DA in MsrA−/− and WT control mice,
selected pharmacological agents were used. Treating brain slices with aMPT while
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electrically stimulating the brain slice depletes DA in RRP vesicles. Under these conditions,
DA in the extracellular space will be packaged and also released, leaving only DA in reserve
pool vesicles (Ortiz et al., 2010). Upon the addition of AMPH, DA in the reverse pool
vesicles is released by reverse transport through the DAT and we are able to measure the
resulting efflux. We found that, compared with WT littermate controls, AMPH-induced DA
efflux is greater in MsrA−/− slices compared to WT slices, indicating that MsrA−/− mice
have an increased supply of reserve pool dopamine. This increase parallels both the
enhancement of stimulated DA release and the increase in striatal DA content found
previously in MsrA−/− mice (Oien et al., 2008b). Because it appears that similar equal levels
of the DAT protein are found in MsrA−/− and WT mice, and DA uptake in the absence of
pharmacological treatments appears to be similar between the two strains, it is unlikely that
the enhancement of DA efflux found in the MsrA−/− striatum is the result of alterations in
DAT expression or function. Thus, our results suggest that the overall amount of reserve
pool DA is increased in the MrsA−/− striatum.
When DA reserve pool vesicles are mobilized by the application of COC, peak DA release
evoked by single-pulse stimulation was the same between the MsrA−/− and WT mice,
implying that there are the same number of DA molecules contained in each mobilized
reserve pool vesicle. Because the peak dopamine release is attained earlier in WT mice than
in MsrA−/− mice, impaired mobilization of reserve pool vesicles in the MsrA−/− cannot be
ruled out. The area under the curve generated from WT slices was about 40% of the area
under the curve generated from MsrA−/− slices. Because the peak amounts of DA released
by WT and MsrA−/− slices following cocaine treatment were unchanged, we speculate that
the genotypes have similar amounts of DA packaged in the vesicles. If this is indeed the
case, then the area under the curve calculations would suggest that the WT striatum
possesses 40% the number of DA reserve pool vesicles found in the MsrA−/− striatum. This
figure is in close agreement with the amount of DA released by electrical stimulation in the
WT striatum (37% of MsrA−/−; Oien et al., 2008b). Thus, it may be that a greater overall
number of vesicles, albeit a similar proportion in relation to the reserve pool, are mobilized
into the RRP in MsrA−/− mice than in WT mice. These vesicles then undergo exocytosis
upon the application of a mild electrical stimulus pulse, which is intended to simulate the
occurrence of a natural action potential. We speculate that this increase in the number of
reserve pool vesicles enhances the magnitude of naturally occurring DA release events in
MsrA−/− mice.
The mechanism of the chronically increased DA levels in MsrA−/− mice is still unknown.
The abnormally high brain DA in MsrA−/− mice can be alleviated by caloric restriction
(Oien et al., 2010), suggesting that metabolism and oxidative stress related mechanisms are
involved in this phenomenon. Previous studies suggest an increase of the tyrosine
hydroxylase activating protein 14-3-3zeta mRNA (Oien et al., 2008a) and protein (Oien et
al., 2008b) may be associated with the increased levels of DA by enhanced DA synthesis. In
addition, we have recently reported that methionine oxidation of the dopamine D2 receptor
may participate in DA signaling in MsrA−/− mice (Oien et al., 2010), which may include the
presynaptic D2 autoreceptor isoform. Another possible explanation for this abnormal DA
regulation is increased methionine sulfoxide levels in alpha-synuclein that may interfere
with its interaction with DA (Oien and Moskovitz, 2008, Oien et al., 2009, Outeiro et al.,
2009). This theory is further supported by defective mobilization of DA from reserve pools
in alpha-synuclein knockout mice and A30P mutated alpha-synuclein transgenic mice
(Yavich et al., 2004, Yavich et al., 2005). In any case, it is apparent that dopaminergic
neurons store this excess DA in reserve pool vesicles.
In summary, this work indicates that MsrA−/− mice have an increase amount of DA stored in
the striatal reserve pool compared to WT control mice. To our knowledge, this is the first
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published study in which reserve pool DA levels have been directly measured in mice that
are genetically altered to have increased oxidative stress. Moreover, this study offers a
potential mechanism by which neurons cope with the excessive production of DA, and also
provides a strategy for the study other DA-related pathologies.
Acknowledgments
This study was supported by funding from NIH P20 RR016475 from the INBRE Program of the National Center
for Research Resources, Huntington's disease Society of America, the KIDDRC HD02528 Center grant, the
National Institute of Aging AG027363 grant, the KU School of Pharmacy General Research Fund, and the
University of Kansas. We would like to thank Renea D. Creech for her technical assistance.
List of Abbreviations
DA dopamine
MsrA−/− methionine sulfoxide reductase A knockout





aCSF artificial cerebral spinal fluid
RRP readily releasable pool
DAT dopamine transporter
References
Bartlett RK, Bieber Urbauer RJ, Anbanandam A, Smallwood HS, Urbauer JL, Squier TC. Oxidation of
Met144 and Met145 in calmodulin blocks calmodulin dependent activation of the plasma membrane
Ca-ATPase. Biochemistry. 2003; 42:3231–3238. [PubMed: 12641454]
Bigelow DJ, Squier TC. Redox modulation of cellular signaling and metabolism through reversible
oxidation of methionine sensors in calcium regulatory proteins. Biochim Biophys Acta. 2005;
1703:121–134. [PubMed: 15680220]
Bird ED, Iversen LL. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase,
choline acetyltransferase and dopamine in basal ganglia. Brain. 1974; 97:457–472. [PubMed:
4157009]
Borges S, Gleason E, Turelli M, Wilson M. The Kinetics of Quantal Transmitter Release from Retinal
Amacrine Cells. Proc Nat Acad Sci USA. 1995; 92:6896–6900. [PubMed: 7624339]
Chen BT, Avshalumov MV, Rice ME. H(2)O(2) is a novel, endogenous modulator of synaptic
dopamine release. J Neurophysiol. 2001; 85:2468–2476. [PubMed: 11387393]
Chiueh CC, Moore KE. D-amphetamine-induced release of "newly synthesized" and "stored"
dopamine from the caudate nucleus in vivo. J Pharmacol Exp Ther. 1975; 192:642–653. [PubMed:
1120962]
Cohen G. The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron
senescence. J Neural Transm Suppl. 1983; 19:89–103. [PubMed: 6321651]
Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell
SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA,
Colbran RJ, Mohler PJ, Anderson ME. A dynamic pathway for calcium-independent activation of
CaMKII by methionine oxidation. Cell. 2008; 133:462–474. [PubMed: 18455987]
Ortiz et al. Page 8













Fischer JF, Cho AK. Chemical release of dopamine from striatal homogenates: evidence for an
exchange diffusion model. J Pharmacol Exp Ther. 1979; 208:203–209. [PubMed: 762652]
Fox AP, Currie KPM. Comparison of N- and P/Q-Type Voltage-Gated Calcium Channel Current
Inhibition. J Neurosci. 1997; 17:4570–4579. [PubMed: 9169518]
Gomis A, Burrone B, Lagnado L. Two actions of calcium regulate the supply of releasable vesicles at
the ribbon synapse of retinal bipolar cells. J Neurosci. 1999; 19:6309–6317. [PubMed: 10414960]
Johnson MA, Rajan V, Miller CE, Wightman RM. Dopamine release is severely compromised in the
R6/2 mouse model of Huntington's disease. J Neurochem. 2006; 97:737–746. [PubMed:
16573654]
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed
in mice lacking the dopamine transporter. J Neurosci. 1998; 18:1979–1986. [PubMed: 9482784]
Kline DD, Takacs KN, Ficker E, Kunze DL. Dopamine Modulates Synaptic Transmission in the
Nucleus of the Solitary Tract. J Neurophysiol. 2002; 88:2736–2744. [PubMed: 12424308]
Kraft JC, Osterhaus GL, Ortiz AN, Garris PA, Johnson MA. In vivo dopamine release and uptake
impairments in rats treated with 3-nitropropionic acid. Neuroscience. 2009; 161:940–949.
[PubMed: 19362126]
Kume-Kick J, Rice ME. Dependence of dopamine calibration factors on media Ca2+ and Mg2+ at
carbon-fiber microelectrodes used with fast-scan cyclic voltammetry. J Neurosci Methods. 1998;
84:55–62. [PubMed: 9821634]
Liang NY, Rutledge CO. Evidence for carrier-mediated efflux of dopamine from corpus striatum.
Biochem Pharmacol. 1982; 31:2479–2484. [PubMed: 7126258]
Michaelis ML, Bigelow DJ, Schoneich C, Williams TD, Ramonda L, Yin D, Huhmer AF, Yao Y, Gao
J, Squier TC. Decreased plasma membrane calcium transport activity in aging brain. Life Sci.
1996; 59:405–412. [PubMed: 8761328]
Morgan DG, May PC, Finch CE. Dopamine and serotonin systems in human and rodent brain: effects
of age and neurodegenerative disease. J Am Geriatr Soc. 1987; 35:334–345. [PubMed: 3549845]
Moskovitz J. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense,
protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta. 2005;
1703:213–219. [PubMed: 15680229]
Moskovitz J. Prolonged selenium-deficient diet in MsrA knockout mice causes enhanced oxidative
modification to proteins and affects the levels of antioxidant enzymes in a tissue-specific manner.
Free Radic Res. 2007; 41:162–171. [PubMed: 17364942]
Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. Methionine sulfoxide
reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad
Sci U S A. 2001; 98:12920–12925. [PubMed: 11606777]
Nachshen DA, Sanchez-Armass S. Co-operative action of calcium ions in dopamine release from rat
brain synaptosomes. J Physiol. 1987; 387:415–423. [PubMed: 3656180]
Neves G, Lagnado L. The kinetics of exocytosis and endocytosis in the synaptic terminal of goldfish
retinal bipolar cells. J Physiol. 1999; 515(Pt 1):181–202. [PubMed: 9925888]
Oien D, Wang X, Moskovitz J. Genomic and Proteomic Analyses of the Methionine Sulfoxide
Reductase A Knockout Mouse. Current Proteomics. 2008a; 5:96–103.
Oien DB, Moskovitz J. Substrates of the methionine sulfoxide reductase system and their
physiological relevance. Curr Top Dev Biol. 2008; 80:93–133. [PubMed: 17950373]
Oien DB, Ortiz AN, Rittel AG, Dobrowsky RT, Johnson MA, Levant B, Fowler SC, Moskovitz J.
Dopamine D2 Receptor Function is Compromised in the Brain of the Methionine Sulfoxide
Reductase A Knockout Mouse. J Neurochem. 2010; 114(1):51–61. [PubMed: 20374422]
Oien DB, Osterhaus GL, Latif SA, Pinkston JW, Fulks J, Johnson M, Fowler SC, Moskovitz J. MsrA
knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Rad Biol Med.
2008b; 45:193–200. [PubMed: 18466776]
Oien DB, Osterhaus GL, Lundquist BL, Fowler SC, Moskovitz J. Caloric restriction alleviates
abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide
reductase A knockout mouse. Neurosci Lett. 2010; 468:38–41. [PubMed: 19854239]
Ortiz et al. Page 9













Oien DB, Shinogle HE, Moore DS, Moskovitz J. Clearance and phosphorylation of alpha-synuclein
are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci. 2009; 39:323–
332. [PubMed: 19653131]
Ortiz AN, Kurth BJ, Osterhaus GL, Johnson MA. Dysregulation of intracellular dopamine stores
revealed in the R6/2 mouse striatum. J Neurochem. 2010; 112:755–761. [PubMed: 19929911]
Outeiro TF, Klucken J, Bercury K, Tetzlaff J, Putcha P, Oliveira LM, Quintas A, McLean PJ, Hyman
BT. Dopamine-induced conformational changes in alpha-synuclein. PLoS One. 2009; 4:e6906.
[PubMed: 19730729]
Pal R, Oien DB, Ersen FY, Moskovitz J. Elevated levels of brain-pathologies associated with
neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain
Res. 2007; 180:765–774. [PubMed: 17333008]
Palacios J, Sepulveda MR, Lee AG, Mata AM. Ca2+ transport by the synaptosomal plasma membrane
Ca2+-ATPase and the effect of thioridazine. Biochemistry. 2004; 43:2353–2358. [PubMed:
14979732]
Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: stuck in the middle of
neurodegeneration. J Alzheimers Dis. 20(Suppl 2):S357–S367. [PubMed: 20421690]
Perez-Severiano F, Santamaria A, Pedraza-Chaverri J, Medina-Campos ON, Rios C, Segovia J.
Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity,
in striata of mice transgenic for the Huntington's disease mutation. Neurochem Res. 2004; 29:729–
733. [PubMed: 15098934]
Rizzoli SO, Betz WJ. Synaptic vesicle pools. Nat Rev Neurosci. 2005; 6:57–69. [PubMed: 15611727]
Rose SD, Lejen T, Casaletti L, Larson RE, Pene TD, Trifaro JM. Molecular motors involved in
chromaffin cell secretion. Ann N Y Acad Sci. 2002; 971:222–231. [PubMed: 12438122]
Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P, Augustine GJ, Wightman RM.
Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J
Neurosci. 2006; 26:3206–3209. [PubMed: 16554471]
Yavich L, Oksman M, Tanila H, Kerokoski P, Hiltunen M, van Groen T, Puolivali J, Mannisto PT,
Garcia-Horsman A, MacDonald E, Beyreuther K, Hartmann T, Jakala P. Locomotor activity and
evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-
synuclein. Neurobiol Dis. 2005; 20:303–313. [PubMed: 16242637]
Yavich L, Tanila H, Vepsalainen S, Jakala P. Role of alpha-synuclein in presynaptic dopamine
recruitment. J Neurosci. 2004; 24:11165–11170. [PubMed: 15590933]
Zucker RS and Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol. 2002; 64:355–405.
[PubMed: 11826273]
Ortiz et al. Page 10














> Dopamine reserve pools were quantified in MsrA−/− mice and WT control
mice
> MsrA−/− mice had an enhanced dopamine reserve pool compared to WT
mice.
> Reserve pool mobilization occurred over a longer time period in MsrA−/−
mice.
> Dopamine release was equally sensitive to extracellular Ca2+ in MsrA−/− and
WT mice.
> Study among first to measure reserve pool dopamine in an oxidative stress
model.
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Figure 1. AMPH induced DA efflux is increased in MsrA−/− mice compared to WT mice
(A) Representative data in which a brain slice from a WT mouse was treated with 50 µM
aMPT while single stimulus pulses were applied every 5 min until DA release was
diminished. The slice was then treated with 20 µM AMPH for 25 min, and DA]AMPH was
measured. A CV is provided from the time of peak release, and confirms the release of DA.
(B) In MsrA−/− mice, [DA]AMPH is significantly higher in MsrA−/− slices than in WT slices
(*p < 0.05; MsrA−/−, 7.02 ± 1.42 µM, n = 5 mice; WT, 5.63 ± 0.33 µM, n = 4).
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Figure 2. More reserve pool DA is mobilized in slices from MsrA−/− mice compared to those
from WT mice
Brain slices from MsrA−/− and WT mice were exposed to 50 µM aMPT while single
stimulus pulses were applied every 5 min. Once DA release disappeared, 20 µM COC was
added to the slice. The application of stimulus pulses was continued during this time. (A)
Representative data from MsrA−/− and WT slices. The addition of COC after pretreatment
with aMPT resulted in an increase in stimulated DA release. Stimulated release plots taken
immediately after the addition of aMPT have been omitted for clarity. (B) Pooled data from
MsrA−/− and WT mice after the addition of COC. Each data point represents the average
value (± SEM) of [DA]stim obtained from 5 MsrA−/− mice and 6 WT mice.
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Figure 3. DAT protein levels are unchanged in MsrA−/− mice
MsrA−/− and WT cerebral membrane fractions were solubilized and equal amounts of
protein were separated by gel electrophoresis followed by western blot analysis. (A) Protein
bands detected by anti-DAT antibodies indicate similar amounts of the protein at about 70
kDa. (B) Densitometry values of DAT protein bands are shown as an average density from
MsrA−/− (black) and WT (white) bands (p = 0.69; n = 3 MsrA−/− and 3 WT mice).
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Figure 4. Calcium-dependent release was unchanged in 12-month-old MsrA−/− mice compared to
age-matched WT mice
Brain slices were treated with 0, 0.6, 1.8, and 2.4 mM concentrations of extracellular
calcium and electrically stimulated DA release was measured for 15 min at each
concentration. DA release was normalized to maximum DA release within each data set. At
0 mM calcium no DA release was detected. Two-way ANOVA did not reveal an overall
genotype effect on DA release throughout the entire range of extracellular calcium
concentrations (Fig. 4; p = 0.51; F1,21 = 0.48; MsrA−/−, n = 4 mice; WT, n = 6 mice).
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